Breaking News

Sepiprod Gains EXCiPACT Certification

By Kristin Brooks | January 21, 2014

Becomes first site in France to be EXCiPACT-registered

Sepiprod, a production site of Seppic based in Castres, France, has received EXCiPACT certification from MDC Medical Device Certification GmbH, one of EXCiPACT’s internationally-recognized Certification Bodies. Seppic is a subsidiary of Air Luquide.
 
The site underwent a rigorous assessment process by EXCiPACT auditors to evaluate GMP/GDP compliance for excipients. Sepiprod is the first site in France to be EXCiPACT-registered. Other certified sites include Aug. Hedinder, BASF, and Merck KGaA in Germany.

Related Contract Manufacturing:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks